SLSBio(Specialty Lab Solution Bio) Co., Ltd

Provides pharma lab services, clinical trial analysis, and innovative diagnostic products.

246250 | KO

Overview

Corporate Details

ISIN(s):: N/A
LEI:
Country:: South Korea
Address:: 경기도 수원시 영통구 창룡대로 260, 광교센트럴비즈타워7층 (이의동), 수원시
Website:: http://www.slabs.co.kr/
Sector:: Mining and quarrying
Industry:: Mining of non-ferrous metal ores

Description

SLSBio (Specialty Lab Solution Bio) Co., Ltd. is a life sciences company that provides a range of specialized services to the pharmaceutical and healthcare industries. The company's core offerings include pharmaceutical quality control, clinical trial sample analysis, bioequivalence testing, and new drug development support. In addition to its contract research services, SLSBio develops diagnostic technologies and test kits, leveraging its proprietary 'NTMD-Technology' platform to create innovative diagnostic products. The company's mission is to contribute to the enhancement of human health through its advanced laboratory solutions and dedicated research.

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for SLSBio(Specialty Lab Solution Bio) Co., Ltd and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Date	Filing	Language	Size
2025-09-08 00:00	Delisting Announcement 기타시장안내 (기업심사위원회 개최 결과 안내)	Korean	3.3 KB
2025-09-08 00:00	Delisting Announcement 주권매매거래정지기간변경 (상장폐지 사유 발생)	Korean	4.9 KB
2025-09-04 00:00	Legal Proceedings Report [기재정정]주요사항보고서(영업정지)	Korean	12.3 KB

Automate Your Workflow. Get a real-time feed of all SLSBio(Specialty Lab Solution Bio) Co., Ltd filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for SLSBio(Specialty Lab Solution Bio) Co., Ltd via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
Poxel Develops drugs for metabolic diseases, including NASH, rare diseases, and an approved diabetes drug.	France	POXEL
PRAP Japan,Inc. A PR & communications firm building brand reputation for corporate clients in diverse industries.	Japan	2449
Psomagen, Inc. A CRO providing multiomics services & data analysis for academic, biotech, and pharma researchers.	United States of America	950200
Public Policy Holding Company, Inc. Advisory group providing public policy, government relations, and strategic communications services.	United States of America	PPHC.L
Purple Biotech Ltd. Developing cancer therapies to overcome tumor immune evasion and drug resistance.	Israel	PPBT
QUIA PHARMA AB Develops biobetters by enhancing approved drugs with a patented drug delivery platform.	Sweden	QUIA
Qurient Co., Ltd. Biopharma developing novel drugs for cancer, inflammation, and infectious diseases.	South Korea	115180
RaQualia Pharma Inc. An R&D firm discovering novel small molecules for out-licensing to pharma partners.	Japan	4579
Recruit Holdings Co., Ltd. Global provider of HR tech (Indeed), staffing services, and business SaaS solutions.	Japan	6098
Renascience Inc. Develops innovative drugs and AI-powered medical devices for aging and hereditary diseases.	Japan	4889